Browsing by Author "Mohsen, Mona O."

Now showing items 1-5 of 5

    • Discovery of Novel Pyridine Derivatives as Anti-Cancer Agents 

      Mohsen, Mona O. (2015 , Master Thesis)
      The International Agency for Research on Cancer indicated that cancer burden was raised in 2012 to 14.1 million incidence cases and 8.2 mortality cases. Consequently, novel approaches are urgently required for further ...

    • Editorial: Vascular Endothelial Growth Factor Inhibitors: Blocking Angiogenesis and Improving Outcomes. 

      Malki, Ahmed; Aziz, Hassan; Mohsen, Mona O. ( OMICS International , 2015 , Article)
      Tumor tissues are just like normal tissues; require nutrients, oxygen and the ability to evacuate waste products and CO2, the process of angiogenesis or (tumor-associated vascularization) addresses these needs to tumor ...

    • Emerging COVID-19 variants and their impact on SARS-CoV-2 diagnosis, therapeutics and vaccines 

      Fernandes, Queenie; Inchakalody, Varghese Philipose; Merhi, Maysaloun; Mestiri, Sarra; Taib, Nassiba; ... more authors ( Taylor and Francis , 2022 , Article)
      The emergence of novel and evolving variants of SARS-CoV-2 has fostered the need for change in the form of newer and more adaptive diagnostic methods for the detection of SARS-CoV-2 infections. On the other hand, developing ...

    • Evidence-Based Medicine; Climbing a Mountain for a Better Decision-Making 

      Mohsen, Mona O.; Malki, Ahmed M.; Abdel-Aziz, Hassan ( Open Access Text , 2015 , Article)
      Evidence-Based Medicine is a relatively new term used in medical sittings and Health Information Technology (HIT). It is a form of medicine that integrates practitioners’ expertise with the best available practical evidences ...

    • Neutralization of MERS coronavirus through a scalable nanoparticle vaccine 

      Mohsen, Mona O; Rothen, Dominik; Balke, Ina; Martina, Byron; Zeltina, Vilija; ... more authors ( Springer Nature , 2021 , Article)
      MERS-CoV continues to cause human outbreaks, so far in 27 countries worldwide following the first registered epidemic in Saudi Arabia in 2012. In this study, we produced a nanovaccine based on virus-like particles (VLPs). ...